HomeRLF • SWX
add
RELIEF THERAPEUTICS Holding SA
Nakaraang pagsara
CHF 2.36
Sakop ng araw
CHF 2.31 - CHF 2.49
Sakop ng taon
CHF 1.06 - CHF 7.60
Market cap
34.89M CHF
Average na Volume
26.15K
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CHF) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.38M | -8.21% |
Gastos sa pagpapatakbo | 2.63M | -48.44% |
Net na kita | -6.28M | 69.86% |
Net profit margin | -454.65 | 67.17% |
Kita sa bawat share | — | — |
EBITDA | -1.45M | 58.14% |
Aktuwal na % ng binabayarang buwis | 18.21% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CHF) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 15.08M | 3.54% |
Kabuuang asset | 53.22M | -30.33% |
Kabuuang sagutin | 16.56M | -31.46% |
Kabuuang equity | 36.66M | — |
Natitirang share | 12.54M | — |
Presyo para makapag-book | 0.81 | — |
Return on assets | -7.07% | — |
Return on capital | -9.70% | — |
Cash Flow
Net change in cash
| (CHF) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -6.28M | 69.86% |
Cash mula sa mga operasyon | 125.00K | 103.50% |
Cash mula sa pag-invest | 2.20M | -50.56% |
Cash mula sa financing | -123.00K | -98.39% |
Net change in cash | 2.18M | 146.71% |
Malayang cash flow | 1.25M | -47.41% |
Tungkol
Relief Therapeutics is a Swiss biopharmaceutical company based in Geneva. The company focuses on developing drugs for serious diseases with few or no existing treatment options. Its lead compound, RLF-100, is a synthetic form of a natural peptide that protects the lung. The company was incorporated as Relief Therapeutics Holdings AG and listed on the SIX Swiss Exchange in 2016. Wikipedia
Itinatag
2013
Website
Mga Empleyado
31
